REXULTI® (brexpiprazole) HCP

REXULTI is available as 2 mg tablets as well as other dosage strengths. Please see IMPORTANT SAFETY INFORMATION by visiting https://tinyurl.com/26tdmdx4. Please see FULL PRESCRIBING INFORMATION, including BOXED WARNING by visiting tinyurl.com/yc6hwy2v. This page is not intended for the reporting of side effects associated with the use of REXULTI. To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch). This content is intended for U.S. HCPs. © 2023 Otsuka America Pharmaceutical, Inc. All rights reserved. April 2023 11US23EBP0103